Palmitoyl Tripeptide-1 Research Guide

Full name: Palmitoyl Tripeptide-1 (Pal-GHK)

A lipopeptide acting as a matrikine, signaling skin repair by mimicking collagen breakdown products that trigger fibroblast collagen production.

How Palmitoyl Tripeptide-1 Works

Functions as matrikine signal, mimicking collagen fragments that trigger fibroblasts to produce new collagen. Palmitoyl enables deeper skin penetration.

Dosing Protocol

• Typical dose: 2-5% in formulation
• Frequency: 1-2x daily
• Duration: 8-16 weeks
• Route: Topical

Reported Benefits

• Collagen synthesis stimulation
• Matrix remodeling
• Wrinkle reduction
• Skin thickness increase

Potential Side Effects

• Very well tolerated
• Rare irritation

Research Citations

1. Matrikine signaling by Pal-GHK in aged skin (2021) - Increased collagen I gene expression by 150% and reduced MMP-1 by 40% in photodamaged skin.
2. Pal-GHK and Pal-GQPR combination (Matrixyl 3000) (2020) - Reduced wrinkle volume by 44% and improved skin tone by 26% over 8 weeks.

Related Skin & Anti-Aging Compounds

• Copper Peptides - Full Profile
• Matrixyl - Full Profile
• Argireline - Full Profile
• Leuphasyl - Full Profile
• SNAP-8 - Full Profile
• Palmitoyl Tetrapeptide-7 - Full Profile

View full Palmitoyl Tripeptide-1 profile with 3D molecule viewer →